ImmunoGenesis
We're breaking down walls around cancer
Founded 2019 · $15.3M raised
- Founded
- 2019
- Website
- immunogenesis.com
- Total Funding
- $15.3M
- Last Round
- $10.8M GrantDec 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
ImmunoGenesis is a clinical-stage immuno-oncology company developing therapies for immune-excluded tumors. Its drug-development strategy targets mechanisms that keep activated T cells outside the tumor bed and limit responses to existing checkpoint inhibitors. The company's lead approach includes IMGS-001, a cytotoxic immune-checkpoint inhibitor designed to break down barriers blocking T cells, provide PD-1 blockade, and activate those cells when they reach the tumor.
Summary
ImmunoGenesis is a Biotech company, founded in 2019. It has raised $15.3M in total across 2 rounds, most recently a $10.8M Grant round in Dec 2025. Investors include Cancer Focus Fund.
Funding History
Dec 2025
Sign up to see all 2 events
Funding: Corporate Round through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunogenesis"><img src="https://indexed.vc/api/badge/company/immunogenesis" alt="ImmunoGenesis on Indexed.vc" width="260" height="76" /></a>